Skip to main content
Top

Fibrogenesis & Tissue Repair

Issue 1/2016

Content (9 Articles)

Open Access Review

Dipeptidyl peptidase-4 and kidney fibrosis in diabetes

Sen Shi, Daisuke Koya, Keizo Kanasaki

Open Access Research

Transcriptomic analysis of the effects of Toll-like receptor 4 and its ligands on the gene expression network of hepatic stellate cells

Yangyang Ouyang, Jinsheng Guo, Chenzhao Lin, Jie Lin, Yirong Cao, Yuanqin Zhang, Yujin Wu, Shiyao Chen, Jiyao Wang, Luonan Chen, Scott L. Friedman

Open Access Review

Biomaterials for hollow organ tissue engineering

Eseelle K. Hendow, Pauline Guhmann, Bernice Wright, Panagiotis Sofokleous, Nina Parmar, Richard M. Day

Open Access Research

Differential effects of hyaluronan synthase 3 deficiency after acute vs chronic liver injury in mice

Jennifer M. McCracken, Lu Jiang, Krutika T. Deshpande, Maura F. O’Neil, Michele T. Pritchard

Open Access Research

Age-dependent development of liver fibrosis in Glmp gt/gt mice

Cecilie K. Nesset, Xiang Yi Kong, Markus Damme, Camilla Schjalm, Norbert Roos, Else Marit Løberg, Winnie Eskild

Open Access Research

Active transforming growth factor-β is associated with phenotypic changes in granulomas after drug treatment in pulmonary tuberculosis

Robert M. DiFazio, Joshua T. Mattila, Edwin C. Klein, Lauren R. Cirrincione, Mondraya Howard, Eileen A. Wong, JoAnne L. Flynn

Open Access Research

Protective role for miR-9-5p in the fibrogenic transformation of human dermal fibroblasts

Verónica Miguel, Oscar Busnadiego, Marta Fierro-Fernández, Santiago Lamas

Open Access Research

Activation of hepatic stellate cell in Pten null liver injury model

Lina He, James Gubbins, Zhechu Peng, Vivian Medina, Fan Fei, Kinji Asahina, Jiaohong Wang, Michael Kahn, Carl B. Rountree, Bangyan L. Stiles

Open Access Research

Matrix and cell phenotype differences in Dupuytren’s disease

Marike M. van Beuge, Evert-Jan P. M. ten Dam, Paul M. N. Werker, Ruud A. Bank

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine